LLY

995

+0.98%↑

JNJ

244.63

+0.97%↑

ABBV

223.63

-0.96%↓

NVS

155.2

+0.73%↑

AZN

191.69

-0.39%↓

LLY

995

+0.98%↑

JNJ

244.63

+0.97%↑

ABBV

223.63

-0.96%↓

NVS

155.2

+0.73%↑

AZN

191.69

-0.39%↓

LLY

995

+0.98%↑

JNJ

244.63

+0.97%↑

ABBV

223.63

-0.96%↓

NVS

155.2

+0.73%↑

AZN

191.69

-0.39%↓

LLY

995

+0.98%↑

JNJ

244.63

+0.97%↑

ABBV

223.63

-0.96%↓

NVS

155.2

+0.73%↑

AZN

191.69

-0.39%↓

LLY

995

+0.98%↑

JNJ

244.63

+0.97%↑

ABBV

223.63

-0.96%↓

NVS

155.2

+0.73%↑

AZN

191.69

-0.39%↓

Начало・Списък с акции・Schrodinger Inc

Schrodinger Inc

Отворен

СекторЗдравеопазване

12.19 -1.93

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

12.44

Ключови измерители
By Trading Economics
Приходи	169M 136M
Продажби	33M 87M
EPS	-0.18
Марж на печалбата	155.644
Служители	850
EBITDA	67M 36M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+60.25% upside

Дивиденти
By Dow Jones
Следващи печалби	6.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	130M 956M
Предишно отваряне	14.12
Предишно затваряне	12.19

Настроения в новините

By Acuity

66%

34%

304 / 351 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

23.27 / 26.13 Подкрепа & съпротива

Schrodinger Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

12.03.2026 г., 23:12 ч. UTC

Горещи акции

Stocks to Watch: Adobe, Mission Produce, Buzzfeed, Ulta

12.03.2026 г., 22:15 ч. UTC

Печалби

Wheaton Precious Metals Logs Higher 4Q Net Income, Boosts Dividend 18%

12.03.2026 г., 21:42 ч. UTC

Значими събития в новините

Stryker Says Cyberattack Disruption Is Continuing

12.03.2026 г., 21:29 ч. UTC

Значими събития в новините

Correction to War in Iran May Upend Brazil Central Bank's Plans Article

12.03.2026 г., 21:27 ч. UTC

Печалби

Adobe CEO to Depart as AI Boosts Sales -- Update

12.03.2026 г., 20:46 ч. UTC

Печалби

Adobe Posts Higher Sales With CEO Set to Depart

12.03.2026 г., 20:21 ч. UTC

Значими събития в новините

Soybean Futures Higher on Instability in Iran --Daily Grain Highlights

12.03.2026 г., 23:57 ч. UTC

Пазарно говорене

Gold Edges Higher Amid Ongoing Middle East Conflict -- Market Talk

12.03.2026 г., 23:38 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

12.03.2026 г., 23:38 ч. UTC

Пазарно говорене

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

12.03.2026 г., 22:13 ч. UTC

Печалби

Orient Overseas: Tariff Measures, Trade Tensions Weighed on Results >0316.HK

12.03.2026 г., 22:13 ч. UTC

Печалби

Orient Overseas: Middle East Situation Have Added to Future Uncertainity >0316.HK

12.03.2026 г., 22:13 ч. UTC

Печалби

Orient Overseas: Charter Market Remains Exceptionally Tight With Vessels in Short Supply >0316.HK

12.03.2026 г., 22:13 ч. UTC

Печалби

Orient Overseas 2025 Rev $9.72B Vs. $10.70B >0316.HK

12.03.2026 г., 22:13 ч. UTC

Печалби

Orient Overseas 2025 Net $1.51B Vs. Net $2.58 >0316.HK

12.03.2026 г., 22:13 ч. UTC

Пазарно говорене

Печалби

Global Equities Roundup: Market Talk

12.03.2026 г., 22:13 ч. UTC

Пазарно говорене

Печалби

Adobe Says Customers Want to Try AI Products for Free First -- Market Talk

12.03.2026 г., 21:16 ч. UTC

Придобивния, сливания и поглъщания

Alexander & Baldwin: JV Formed by Affil of MW Group and Funds Affiliated With Blackstone and DivcoWest Completed Acquisition of All Outstanding A&B Common Shrs >ALEX

12.03.2026 г., 21:04 ч. UTC

Печалби

Adobe Earnings Beat Is Overshadowed by CEO Departure. The Stock Is Sliding. -- Barrons.com

12.03.2026 г., 21:02 ч. UTC

Печалби

Wheaton Precious Metals 4Q Adj EPS $1.22 >WPM

12.03.2026 г., 21:02 ч. UTC

Печалби

Wheaton Precious Metals 4Q Sales $865M >WPM

12.03.2026 г., 21:02 ч. UTC

Печалби

Wheaton Precious Metals 4Q Net $558.3M >WPM

12.03.2026 г., 21:02 ч. UTC

Печалби

Wheaton Precious Metals 4Q EPS $1.23 >WPM

12.03.2026 г., 20:57 ч. UTC

Пазарно говорене

Значими събития в новините

No Need For Canada Rate Increases Amid Jump in Bond Yields -- Market Talk

12.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

12.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

12.03.2026 г., 20:15 ч. UTC

Придобивния, сливания и поглъщания

Eaton Completes Acquisition Of Leading Liquid-cooling Solutions Provider Boyd Thermal, Creating An Industry-leading Grid-to-chip Solution For Data Centers >ETN

12.03.2026 г., 20:10 ч. UTC

Печалби

Adobe Sees 2Q Rev $6.43B-$6.48B >ADBE

12.03.2026 г., 20:05 ч. UTC

Печалби

Adobe 1Q Rev $6.4B >ADBE

12.03.2026 г., 20:05 ч. UTC

Печалби

Adobe Sees 2Q Adj EPS $5.80-Adj EPS $5.85 >ADBE

Сравнение с други в отрасъла

Ценова промяна

Schrodinger Inc Прогноза

Ценова цел

By TipRanks

60.25% нагоре

12-месечна прогноза

Среден 20.4 USD 60.25%

Висок 25 USD

Нисък 18 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Schrodinger Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

6 ratings

Купи

Задържане

Продай

Според 6 анализатори, дали борсови рейтинги на Schrodinger Inc през последните 3 месеца.

Техническа оценка

By Trading Central

23.27 / 26.13Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bullish.

Настроение

By Acuity

304 / 351 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.